2023 Q4 Form 10-Q Financial Statement

#000127344123000027 Filed on November 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $154.9M $179.9M
YoY Change -4.73% 6.84%
Cost Of Revenue $51.58M $53.21M
YoY Change 6.24% 20.24%
Gross Profit $103.4M $126.7M
YoY Change -9.4% 2.07%
Gross Profit Margin 66.71% 70.43%
Selling, General & Admin $13.05M $10.24M
YoY Change 22.26% 26.18%
% of Gross Profit 12.62% 8.08%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $52.63M $55.05M
YoY Change 1.65% 21.47%
% of Gross Profit 50.92% 43.44%
Operating Expenses $66.65M $64.90M
YoY Change 6.72% 21.46%
Operating Profit $36.71M $61.81M
YoY Change -28.9% -12.59%
Interest Expense -$21.20M -$14.95M
YoY Change 71.1% 15.79%
% of Operating Profit -57.76% -24.19%
Other Income/Expense, Net -$2.297M
YoY Change -188.41%
Pretax Income $13.21M $46.86M
YoY Change -66.34% -22.41%
Income Tax $5.499M $40.33M
% Of Pretax Income 41.63% 86.07%
Net Earnings $7.711M $6.527M
YoY Change -76.83% -83.12%
Net Earnings / Revenue 4.98% 3.63%
Basic Earnings Per Share $0.20
Diluted Earnings Per Share $0.23 $0.20
COMMON SHARES
Basic Shares Outstanding 33.29M shares 33.29M shares
Diluted Shares Outstanding 33.35M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $62.15M $123.2M
YoY Change -51.02% 4.27%
Cash & Equivalents $62.15M $123.2M
Short-Term Investments
Other Short-Term Assets $8.920M $12.08M
YoY Change -70.08% 0.39%
Inventory $29.04M $25.72M
Prepaid Expenses
Receivables $12.36M $19.16M
Other Receivables $0.00 $0.00
Total Short-Term Assets $112.5M $181.3M
YoY Change -33.29% 12.76%
LONG-TERM ASSETS
Property, Plant & Equipment $1.143B $1.141B
YoY Change 3.81% 8.04%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.963M $7.265M
YoY Change -48.07% -59.35%
Total Long-Term Assets $1.214B $1.205B
YoY Change 4.01% 7.8%
TOTAL ASSETS
Total Short-Term Assets $112.5M $181.3M
Total Long-Term Assets $1.214B $1.205B
Total Assets $1.326B $1.386B
YoY Change -0.7% 8.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $174.9M $166.5M
YoY Change 7.45% -6.69%
Accrued Expenses $12.10M $10.00M
YoY Change 152.08% 284.62%
Deferred Revenue
YoY Change
Short-Term Debt $35.61M $49.07M
YoY Change
Long-Term Debt Due $0.00 $50.00M
YoY Change
Total Short-Term Liabilities $260.3M $279.7M
YoY Change 7.7% 25.85%
LONG-TERM LIABILITIES
Long-Term Debt $519.5M $587.4M
YoY Change -11.88% 2.04%
Other Long-Term Liabilities $10.88M $9.055M
YoY Change 55.63% 24.01%
Total Long-Term Liabilities $669.6M $711.7M
YoY Change -1.0% 7.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $260.3M $279.7M
Total Long-Term Liabilities $669.6M $711.7M
Total Liabilities $929.9M $991.5M
YoY Change 1.29% 12.45%
SHAREHOLDERS EQUITY
Retained Earnings -$863.0M -$870.7M
YoY Change 0.73% -2.17%
Common Stock $9.936M $10.24M
YoY Change -3.27% -0.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $396.4M $394.5M
YoY Change
Total Liabilities & Shareholders Equity $1.326B $1.386B
YoY Change -0.7% 8.42%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $7.711M $6.527M
YoY Change -76.83% -83.12%
Depreciation, Depletion And Amortization $52.63M $55.05M
YoY Change 1.65% 21.47%
Cash From Operating Activities $70.48M $70.41M
YoY Change -1.93% -35.3%
INVESTING ACTIVITIES
Capital Expenditures $39.18M $43.11M
YoY Change -46.25% -175.58%
Acquisitions
YoY Change
Other Investing Activities $3.349M -$20.15M
YoY Change -85.45% 161.4%
Cash From Investing Activities -$35.83M -$63.26M
YoY Change -28.16% -2.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -95.00M 47.90M
YoY Change 610.91% -247.58%
NET CHANGE
Cash From Operating Activities 70.48M 70.41M
Cash From Investing Activities -35.83M -63.26M
Cash From Financing Activities -95.00M 47.90M
Net Change In Cash -60.34M 55.05M
YoY Change -798.99% 373.71%
FREE CASH FLOW
Cash From Operating Activities $70.48M $70.41M
Capital Expenditures $39.18M $43.11M
Free Cash Flow $31.31M $27.30M
YoY Change -3163.21% -83.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1717000 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1489000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-8126000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-486000 usd
CY2022Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.88
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
123216000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1142000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1142000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19157000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10706000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
25724000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
20192000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
28000 usd
CY2022Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
63358000 usd
CY2022Q4 gte Sharebased Compensation Arrangement Recorded Liability Fair Value Disclosure Noncurrent
SharebasedCompensationArrangementRecordedLiabilityFairValueDisclosureNoncurrent
16437000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6989000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
676405000 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34615116 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
10272000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1291354000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
27317000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-856743000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
417566000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1335610000 usd
us-gaap Net Income Loss
NetIncomeLoss
105754000 usd
us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
128499000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
36868000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
6376000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2769000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
157511000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
355846000 usd
us-gaap Payments To Acquire Oil And Gas Property And Equipment
PaymentsToAcquireOilAndGasPropertyAndEquipment
179707000 usd
us-gaap Payments To Acquire Oil And Gas Property And Equipment
PaymentsToAcquireOilAndGasPropertyAndEquipment
163717000 usd
gte Increase Decreasein Investing Working Capital
IncreaseDecreaseinInvestingWorkingCapital
-11051000 usd
gte Increase Decreasein Investing Working Capital
IncreaseDecreaseinInvestingWorkingCapital
3255000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-190758000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-160462000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
10825000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
14365000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1294000 usd
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
5101000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5897000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1996000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1948000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
93429000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31404000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
131410000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
124833000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
568917000 usd
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
20676000 usd
CY2023Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
636511000 usd
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://grantierra.com/20230930#OilSalesMember
CY2022Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://grantierra.com/20230930#OilSalesMember
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://grantierra.com/20230930#OilSalesMember
CY2023Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2023Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2023Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2023Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
126873000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
12082000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
9674000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
181321000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
168587000 usd
CY2023Q3 us-gaap Capitalized Costs Proved Properties
CapitalizedCostsProvedProperties
1040254000 usd
CY2022Q4 us-gaap Capitalized Costs Proved Properties
CapitalizedCostsProvedProperties
1000424000 usd
CY2023Q3 us-gaap Capitalized Costs Unproved Properties
CapitalizedCostsUnprovedProperties
70253000 usd
CY2022Q4 us-gaap Capitalized Costs Unproved Properties
CapitalizedCostsUnprovedProperties
74471000 usd
CY2023Q3 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
1110507000 usd
CY2022Q4 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
1074895000 usd
CY2023Q3 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
30448000 usd
CY2022Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
26007000 usd
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
1140955000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
1100902000 usd
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9758000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
22990000 usd
CY2023Q3 gte Taxes Receivable Noncurrent
TaxesReceivableNoncurrent
46736000 usd
CY2022Q4 gte Taxes Receivable Noncurrent
TaxesReceivableNoncurrent
27796000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7265000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15335000 usd
CY2023Q3 gte Total Other Long Term Assets
TotalOtherLongTermAssets
63759000 usd
CY2022Q4 gte Total Other Long Term Assets
TotalOtherLongTermAssets
66121000 usd
CY2023Q3 us-gaap Assets
Assets
1386035000 usd
CY2022Q4 us-gaap Assets
Assets
1335610000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
176489000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
167579000 usd
CY2023Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
49067000 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
58978000 usd
CY2022Q4 gte Share Based Compensation Arrangement Recorded Liability Fair Value Disclosure Current
ShareBasedCompensationArrangementRecordedLiabilityFairValueDisclosureCurrent
15082000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
241639000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
589593000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-6138000 usd
gte Gain Loss On Impairment And Sale Of Bonds
GainLossOnImpairmentAndSaleOfBonds
2598000 usd
gte Derivative Gain Loss On Derivative Net1
DerivativeGainLossOnDerivativeNet1
0 usd
gte Derivative Gain Loss On Derivative Net1
DerivativeGainLossOnDerivativeNet1
-26611000 usd
gte Cash Settlement Of Financial Instruments
CashSettlementOfFinancialInstruments
0 usd
gte Cash Settlement Of Financial Instruments
CashSettlementOfFinancialInstruments
-26611000 usd
us-gaap Asset Retirement Obligation Cash Paid To Settle
AssetRetirementObligationCashPaidToSettle
376000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
3488000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2009000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1918000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
1134000 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
34235000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
48125000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 usd
gte Repayments Of Long Term Debt1
RepaymentsOfLongTermDebt1
0 usd
gte Repayments Of Long Term Debt1
RepaymentsOfLongTermDebt1
67623000 usd
gte Payment To Repurchase Senior Debt
PaymentToRepurchaseSeniorDebt
6805000 usd
gte Payment To Repurchase Senior Debt
PaymentToRepurchaseSeniorDebt
17274000 usd
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
1991000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25402000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-99959000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
394540000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
396600000 usd
us-gaap Nature Of Operations
NatureOfOperations
Description of Business Gran Tierra Energy Inc. a Delaware corporation (the “Company” or “Gran Tierra”), is a publicly traded company focused on international oil and natural gas exploration and production with assets currently in Colombia and Ecuador.
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
34623000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
32974000 usd
CY2023Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1594000 usd
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
4951452000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
4753661000 usd
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
3810497000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
3652759000 usd
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
1140955000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
1100902000 usd
CY2023Q3 gte Operating Leaseand Finance Lease Rightof Use Assetbefore Accumulated Amortization
OperatingLeaseandFinanceLeaseRightofUseAssetbeforeAccumulatedAmortization
47900000 usd
CY2023Q3 gte Operating Lease And Finance Lease Right Of Use Asset After Accumulated Amortization
OperatingLeaseAndFinanceLeaseRightOfUseAssetAfterAccumulatedAmortization
29300000 usd
CY2022Q4 gte Operating Leaseand Finance Lease Rightof Use Assetbefore Accumulated Amortization
OperatingLeaseandFinanceLeaseRightofUseAssetbeforeAccumulatedAmortization
38900000 usd
CY2022Q4 gte Operating Lease And Finance Lease Right Of Use Asset After Accumulated Amortization
OperatingLeaseAndFinanceLeaseRightOfUseAssetAfterAccumulatedAmortization
24600000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
50000000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2023Q3 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
933000 usd
CY2022Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
0 usd
CY2023Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
49067000 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 usd
CY2023Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
8334000 usd
CY2022Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
10992000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
563575000 usd
CY2023Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
23869000 usd
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
587444000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
589593000 usd
CY2022Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
589593000 usd
CY2023Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
10000000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
4800000 usd
CY2023Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
11909000 usd
CY2022Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
10670000 usd
CY2022Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
751000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3394000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2769000 usd
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
13503000 usd
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
11421000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
38017000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
35743000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1730286 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.52
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
409435 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.58
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1839 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.17
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
22336 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.79
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
133880 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
25.15
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1981666 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.06
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1900000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3700000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-200000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6400000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
11400000 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
10500000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M18D
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1142000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1142000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1142000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33287368 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36730543 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33675160 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36775419 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
129299 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1133014 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1202431 shares
CY2023Q3 gte Shares To Be Purchased From Proceeds Of Stock Options
SharesToBePurchasedFromProceedsOfStockOptions
66617 shares
CY2022Q3 gte Shares To Be Purchased From Proceeds Of Stock Options
SharesToBePurchasedFromProceedsOfStockOptions
732483 shares
gte Shares To Be Purchased From Proceeds Of Stock Options
SharesToBePurchasedFromProceedsOfStockOptions
0 shares
gte Shares To Be Purchased From Proceeds Of Stock Options
SharesToBePurchasedFromProceedsOfStockOptions
739060 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33350050 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37131074 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33675160 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37238790 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1854307 shares
CY2023Q3 gte Revenue Information Used To Assess Variable Consideration Constraint Adjustment For Quality And Transportation
RevenueInformationUsedToAssessVariableConsiderationConstraintAdjustmentForQualityAndTransportation
0.14
gte Revenue Information Used To Assess Variable Consideration Constraint Adjustment For Quality And Transportation
RevenueInformationUsedToAssessVariableConsiderationConstraintAdjustmentForQualityAndTransportation
0.18
CY2022Q3 gte Revenue Information Used To Assess Variable Consideration Constraint Adjustment For Quality And Transportation
RevenueInformationUsedToAssessVariableConsiderationConstraintAdjustmentForQualityAndTransportation
0.14
gte Revenue Information Used To Assess Variable Consideration Constraint Adjustment For Quality And Transportation
RevenueInformationUsedToAssessVariableConsiderationConstraintAdjustmentForQualityAndTransportation
0.13
CY2023Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.15
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.49
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
63700000 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
63100000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
43200000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
36900000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.15
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.49
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
392000 usd
CY2023Q3 gte Debt Instrument Collateral Letters Of Credit And Other Credit Support Provided As Security
DebtInstrumentCollateralLettersOfCreditAndOtherCreditSupportProvidedAsSecurity
220100000 usd
CY2022Q4 gte Debt Instrument Collateral Letters Of Credit And Other Credit Support Provided As Security
DebtInstrumentCollateralLettersOfCreditAndOtherCreditSupportProvidedAsSecurity
111100000 usd
CY2023Q3 gte Prepaid Equity Forwards Notional Amount Shares
PrepaidEquityForwardsNotionalAmountShares
1000000 shares
CY2023Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
7000000 usd
CY2022Q4 gte Prepaid Equity Forwards Notional Amount Shares
PrepaidEquityForwardsNotionalAmountShares
1600000 shares
CY2022Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
16000000 usd
CY2023Q3 gte Gain Loss On Prepaid Equity Forwards
GainLossOnPrepaidEquityForwards
2200000 usd
gte Gain Loss On Prepaid Equity Forwards
GainLossOnPrepaidEquityForwards
-3600000 usd
CY2022Q3 gte Gain Loss On Prepaid Equity Forwards
GainLossOnPrepaidEquityForwards
2600000 usd
gte Gain Loss On Prepaid Equity Forwards
GainLossOnPrepaidEquityForwards
5300000 usd
CY2022Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-26600000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
123216000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118173000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
126873000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26109000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7052000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5518000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
5343000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4903000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
131410000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
124833000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
133358000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31404000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
8484000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-2811000 usd
us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
0 usd
us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
2757000 usd
gte Increase Decrease Prepaid Equity Forward
IncreaseDecreasePrepaidEquityForward
-9664000 usd
gte Increase Decrease Prepaid Equity Forward
IncreaseDecreasePrepaidEquityForward
13837000 usd
gte Increase Decrease In Prepaid Expenses And Inventory
IncreaseDecreaseInPrepaidExpensesAndInventory
6809000 usd
gte Increase Decrease In Prepaid Expenses And Inventory
IncreaseDecreaseInPrepaidExpensesAndInventory
6025000 usd
gte Increase Decrease In Accounts Payable And Accrued And Other Long Term Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedAndOtherLongTermLiabilities
-3040000 usd
gte Increase Decrease In Accounts Payable And Accrued And Other Long Term Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedAndOtherLongTermLiabilities
37862000 usd
gte Increase Decrease In Prepaid Taxes And Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInPrepaidTaxesAndIncomeTaxesPayableNetOfIncomeTaxesReceivable
-25566000 usd
gte Increase Decrease In Prepaid Taxes And Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInPrepaidTaxesAndIncomeTaxesPayableNetOfIncomeTaxesReceivable
54784000 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
34235000 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-72838000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-11000000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
100000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3700000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
400000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
85203000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
29881000 usd
us-gaap Interest Paid Net
InterestPaidNet
29446000 usd
us-gaap Interest Paid Net
InterestPaidNet
31455000 usd
CY2023Q3 gte Liabilities Relatedto Property Plantand Equipment Net
LiabilitiesRelatedtoPropertyPlantandEquipmentNet
44067000 usd
CY2022Q3 gte Liabilities Relatedto Property Plantand Equipment Net
LiabilitiesRelatedtoPropertyPlantandEquipmentNet
33397000 usd
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001273441-23-000027-index-headers.html Edgar Link pending
0001273441-23-000027-index.html Edgar Link pending
0001273441-23-000027.txt Edgar Link pending
0001273441-23-000027-xbrl.zip Edgar Link pending
a20230930-ex101.htm Edgar Link pending
a20230930-ex311.htm Edgar Link pending
a20230930-ex312.htm Edgar Link pending
a20230930-ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gte-20230930.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gte-20230930.xsd Edgar Link pending
gte-20230930_g1.jpg Edgar Link pending
gte-20230930_g2.jpg Edgar Link pending
gte-20230930_g3.jpg Edgar Link pending
gte-20230930_g4.jpg Edgar Link pending
gte-20230930_g5.jpg Edgar Link pending
gte-20230930_g6.jpg Edgar Link pending
gte-20230930_g7.jpg Edgar Link pending
gte-20230930_g8.jpg Edgar Link pending
image_0a.jpg Edgar Link pending
image_13a.jpg Edgar Link pending
image_15.jpg Edgar Link pending
image_16a.jpg Edgar Link pending
image_19a.jpg Edgar Link pending
image_1a.jpg Edgar Link pending
image_20.jpg Edgar Link pending
image_21a.jpg Edgar Link pending
image_26.jpg Edgar Link pending
image_27a.jpg Edgar Link pending
image_28a.jpg Edgar Link pending
image_29a.jpg Edgar Link pending
image_30a.jpg Edgar Link pending
image_31.jpg Edgar Link pending
image_3a.jpg Edgar Link pending
image_41a.jpg Edgar Link pending
image_42a.jpg Edgar Link pending
image_4a.jpg Edgar Link pending
image_52a.jpg Edgar Link pending
image_53a.jpg Edgar Link pending
image_54.jpg Edgar Link pending
image_57a.jpg Edgar Link pending
image_5a.jpg Edgar Link pending
image_62.jpg Edgar Link pending
image_6a.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
gte-20230930_lab.xml Edgar Link unprocessable
gte-20230930_pre.xml Edgar Link unprocessable
gte-20230930_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
gte-20230930_cal.xml Edgar Link unprocessable
gte-20230930_def.xml Edgar Link unprocessable